New Release of Cenduit IRT Platform Supports Advancements in IRT Technologies and Configurable Capabilities
May 28, 2019– Durham, NC – Cenduit LLC continues to redefine innovation in IRT (Interactive Response Technology) and eClinical technologies with the latest release of its market-leading Cenduit IRT (CIRT) platform.
The new release strengthens Cenduit’s underlying technology, streamlining an array of configurable capabilities for both sponsors and sites. New capabilities include more accessible self-service tools, which enable sites to devote more time to every trial’s most important stakeholders – the patients.
Chris Dailey, Cenduit Global Vice President of Technology, explained, “Cenduit continues to be a leader in helping sponsors tailor their unique trial requirements. Our focus centers on providing quality-first systems and services that assure consistency, repeatability, and proactively design for change throughout the entire study lifecycle.”
The latest enhancements continue to expand the capabilities of Cenduit’s configurable and customizable platform. Recognizing that every client has a unique set of standards and requirements, an IRT system that is both configurable and tailored to accelerate specific and unique trial requirements can meet the needs of the most complex studies. CIRT capabilities include…
● Site User Dashboard – Responsive, agile design enables site users to easily log into the dashboard, accomplish key tasks, and use minimal keystrokes and fewer clicks to prioritize actions, and view action tasks and upcoming activities. Sites also can quickly review previous tasks and access email screenshots, as well as safeguard and prevent potential unblinding.
● Patient API Gateway for Siteless Trials – Cenduit’s extendable API Gateway seamlessly integrates with partners, sponsors and CMOs to support the adoption of Direct-to-Patient (DTP) and siteless trials. DTP enhancements include support for combination shipments, improved abilities to initiate replacement kits via the API, and obtaining additional patient statuses.
● Support for Sites and Central Pharmacy Setup – Cenduit’s unparalleled experience supporting sites and central pharmacy set up raises the bar for standardization and configuration of this complex supply scenario. Additional configuration for activities include raising orders to the central pharmacy and the ability to improve and expedite kit shipments.
About Cenduit LLC
Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise and client-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps clients manage clinical studies in over 100 countries, interacting with over 1,000,000 patients at nearly 33,000 sites. Visit www.cenduit.com for more information.
Contact:
Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393
Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253